Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
26.74
-0.38 (-1.40%)
At close: Apr 28, 2026, 4:00 PM EDT
26.72
-0.02 (-0.07%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.58 billion as of April 28, 2026. Its market cap has increased by 78.28% in one year.
Market Cap
1.58B
Enterprise Value
1.32B
1-Year Change
78.28%
Ranking
Category
Stock Price
$26.74
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.58B, an increase of 893.93%. That is a compound annual growth rate of 59.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.58B | 36.95% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.63B |
| Intellia Therapeutics | 1.61B |
| Nanobiotix | 1.60B |
| Monte Rosa Therapeutics | 1.58B |
| Immatics | 1.52B |
| MBX Biosciences | 1.52B |
| Damora Therapeutics | 1.49B |
| Immunocore Holdings | 1.49B |